Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells

por Kim, Marianne K, James, Jana, Annunziata, Christina M
Publicado 2015

Loss of compensatory pro-survival and anti-apoptotic modulator, IKKε, sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21

por Kim, Marianne K., Min, Dong J., Wright, George, Goldlust, Ian, Annunziata, Christina M.
Publicado 2014

Identification of therapeutic targets applicable to clinical strategies in ovarian cancer

por Kim, Marianne K., Caplen, Natasha, Chakka, Sirisha, Hernandez, Lidia, House, Carrie, Pongas, Georgios, Jordan, Elizabeth, Annunziata, Christina M.
Publicado 2016

IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts

por House, Carrie D., Grajales, Valentina, Ozaki, Michelle, Jordan, Elizabeth, Wubneh, Helmae, Kimble, Danielle C., James, Jana M., Kim, Marianne K., Annunziata, Christina M.
Publicado 2018

BRD4 facilitates DNA damage response and represses CBX5/Heterochromatin protein 1 (HP1)

por Pongas, Georgios, Kim, Marianne K., Min, Dong J., House, Carrie D., Jordan, Elizabeth, Caplen, Natasha, Chakka, Sirisha, Ohiri, Joyce, Kruhlak, Michael J., Annunziata, Christina M.
Publicado 2017

Sprouty Proteins Inhibit Receptor-mediated Activation of Phosphatidylinositol-specific Phospholipase C

por Akbulut, Simge, Reddi, Alagarsamy L., Aggarwal, Priya, Ambardekar, Charuta, Canciani, Barbara, Kim, Marianne K.H., Hix, Laura, Vilimas, Tomas, Mason, Jacqueline, Basson, M. Albert, Lovatt, Matthew, Powell, Jonathan, Collins, Samuel, Quatela, Steven, Phillips, Mark, Licht, Jonathan D.
Publicado 2010